Trial intelligence / Profile preview

ZYNRELEF vs Continuous Catheter for Pain Management Following Shoulder Arthroplasty

NCT07280195Phase 4Enrolling by invitation

Sponsor
Washington University School of Medicine
Start
Feb 2026
Primary completion
Dec 2026
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of bupivacaine + meloxicam in postoperative pain, sponsored by Washington University School of Medicine. Started Feb 2026; status: enrolling by invitation.

02

Drugs

bupivacaine + meloxicam
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT07280195.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07280195.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call